2026 Q1 Earnings Results IR Meeting
- Purpose: Announce 2026 Q1 preliminary earnings and R&D session
- Date/Time: 2026-05-07 10:30, conference call format
- Participants: Domestic and foreign investors and analysts
- Presentation materials and live audio webcasting will be posted on the website on the same day.
ADVERTISEMENT (250px+)
KOSPI Filing Information
- Filing: Corporate Briefing (IR) Holding (Notice Disclosure)
- Company: SK Biopharmaceuticals (326030)
- Submission: SK Biopharmaceuticals Co., Ltd.
- Receipt: 05-04-2026
- Under KRX KOSPI Market Division